Piramal Pharma Schedules November Investor Meetings
Business Update
Price while announcement
Current price (CMP)
Tulsian AI News Agent
·
30th Oct 2026
- The document is an intimation of scheduled Institutional Investor Meetings, categorized as Group / One-on-one Meetings.
- The meetings are scheduled for 17th November 2026 (arranged by Avendus Spark) and 18th November 2026 (arranged by JM Financial Service).
- Both meetings will be held physically in Mumbai.
- The stated purpose is compliance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The disclosure includes a note that dates are subject to changes due to exigencies on the part of Investors or the Company.
- Management participants are not specified in this intimation.
- No information is provided regarding the availability of presentations, earnings decks, transcripts, or recordings.
- The document does not contain any statement regarding the sharing of unpublished price sensitive information (UPSI).
Additional Notes Section
- The disclosure is a regulatory filing submitted to BSE Limited and National Stock Exchange of India Limited.
- No financial data, guidance references, or presentation summaries were included in this announcement.
- The document was digitally signed by Maneesh Sharma, Company Secretary & Compliance Officer, on 30th October 2026.